Collaborative virtual screening to elaborate an imidazo[1,2-


Journal

RSC medicinal chemistry
ISSN: 2632-8682
Titre abrégé: RSC Med Chem
Pays: England
ID NLM: 101759460

Informations de publication

Date de publication:
21 Jan 2021
Historique:
entrez: 27 5 2021
pubmed: 28 5 2021
medline: 28 5 2021
Statut: epublish

Résumé

An innovative pre-competitive virtual screening collaboration was engaged to validate and subsequently explore an imidazo[1,2-

Identifiants

pubmed: 34041487
doi: 10.1039/d0md00353k
pii: d0md00353k
pmc: PMC8130605
doi:

Types de publication

Journal Article

Langues

eng

Pagination

384-393

Informations de copyright

This journal is © The Royal Society of Chemistry.

Déclaration de conflit d'intérêts

There are no conflicts to declare.

Références

J Med Chem. 2014 Oct 23;57(20):8664-70
pubmed: 25238611
Nat Rev Drug Discov. 2015 Nov;14(11):751-8
pubmed: 26435527
Lancet. 2016 Oct 8;388(10053):1603-1658
pubmed: 27733283
Drugs. 2013 Nov;73(17):1863-88
pubmed: 24170666
Nat Rev Microbiol. 2007 Nov;5(11):873-82
pubmed: 17938629
Molecules. 2019 Oct 28;24(21):
pubmed: 31661934
Drug Discov Today. 2019 May;24(5):1209-1216
pubmed: 30876846
ACS Chem Biol. 2012 Jul 20;7(7):1190-7
pubmed: 22500615
ACS Med Chem Lett. 2020 Jan 10;11(3):249-257
pubmed: 32184953
Nat Biotechnol. 2014 Jan;32(1):40-51
pubmed: 24406927
PLoS One. 2012;7(5):e35671
pubmed: 22693548
Br J Pharmacol. 2011 Mar;162(6):1239-49
pubmed: 21091654
Nature. 2016 Sep 8;537(7619):229-233
pubmed: 27501246
Nat Rev Drug Discov. 2015 Jul;14(7):475-86
pubmed: 26091267
Am J Trop Med Hyg. 1999 Nov;61(5):766-9
pubmed: 10586909
J Chem Inf Model. 2010 May 24;50(5):742-54
pubmed: 20426451
J Med Chem. 2011 May 12;54(9):3260-7
pubmed: 21438571
Parasitology. 2018 Feb;145(2):219-236
pubmed: 28805165
Lancet. 2018 Sep 15;392(10151):951-970
pubmed: 30126638
J Med Chem. 2013 Oct 24;56(20):7719-26
pubmed: 24015767
Eur J Med Chem. 2017 Jan 27;126:353-368
pubmed: 27907874
J Med Chem. 2010 Apr 8;53(7):2719-40
pubmed: 20131845
J Biomed Biotechnol. 2010;2010:617521
pubmed: 19888437
J Med Chem. 2019 Feb 14;62(3):1180-1202
pubmed: 30570265
Int J Parasitol Drugs Drug Resist. 2018 Apr;8(1):81-86
pubmed: 29425734
Eur J Med Chem. 2012 Dec;58:543-56
pubmed: 23164660
J Med Chem. 2007 Jan 11;50(1):74-82
pubmed: 17201411
Drug Discov Today. 2013 Oct;18(19-20):1014-24
pubmed: 23127858
Proc Natl Acad Sci U S A. 2019 May 7;116(19):9318-9323
pubmed: 30962368
Trends Parasitol. 2006 Dec;22(12):552-7
pubmed: 17023215
Mar Drugs. 2020 Mar 31;18(4):
pubmed: 32244488
Chem Rev. 2014 Nov 26;114(22):11305-47
pubmed: 25365529

Auteurs

Yuichiro Akao (Y)

Takeda Pharmaceutical Company Limited 26-1 Muraoka-Higashi 2-chrome Fujisawa Kanagawa 251-8555 Japan.

Stacie Canan (S)

Celgene Corporation, Celgene Global Health 10300 Campus Point Drive San Diego California 92121 USA.

Yafeng Cao (Y)

WuXi AppTec Company Ltd. 666 Gaoxin Road, East Lake High-Tech Development Zone Wuhan 430075 People's Republic of China.

Kevin Condroski (K)

Celgene Corporation, Celgene Global Health 10300 Campus Point Drive San Diego California 92121 USA.

Ola Engkvist (O)

AstraZeneca Discovery Sciences, R&D AstraZeneca Gothenburg Sweden.

Sachiko Itono (S)

Takeda Pharmaceutical Company Limited 26-1 Muraoka-Higashi 2-chrome Fujisawa Kanagawa 251-8555 Japan.

Rina Kaki (R)

Shionogi & Co., Ltd 3-1-1, Futaba-cho Toyonaka-shi Osaka Japan.

Chiaki Kimura (C)

Shionogi & Co., Ltd 3-1-1, Futaba-cho Toyonaka-shi Osaka Japan.

Thierry Kogej (T)

AstraZeneca Discovery Sciences, R&D AstraZeneca Gothenburg Sweden.

Kazuya Nagaoka (K)

Eisai Co., Ltd 1-3,Tokodai 5-chome Tsukuba Ibaraki 300-2635 Japan.

Akira Naito (A)

Shionogi & Co., Ltd 3-1-1, Futaba-cho Toyonaka-shi Osaka Japan.

Hiromi Nakai (H)

Shionogi & Co., Ltd 3-1-1, Futaba-cho Toyonaka-shi Osaka Japan.

Garry Pairaudeau (G)

AstraZeneca, Discovery Sciences, R&D AstraZeneca Cambridge UK.

Constantin Radu (C)

Institut Pasteur Korea 16, Daewangpangyo-ro 712 beon-gil, Bundang-gu Seongnam-si Gyeonggi-do 13488 Republic of Korea.

Ieuan Roberts (I)

AstraZeneca, Discovery Sciences, R&D AstraZeneca Cambridge UK.

Mitsuyuki Shimada (M)

Takeda Pharmaceutical Company Limited 26-1 Muraoka-Higashi 2-chrome Fujisawa Kanagawa 251-8555 Japan.

David Shum (D)

Institut Pasteur Korea 16, Daewangpangyo-ro 712 beon-gil, Bundang-gu Seongnam-si Gyeonggi-do 13488 Republic of Korea.

Nao-Aki Watanabe (NA)

Eisai Co., Ltd 1-3,Tokodai 5-chome Tsukuba Ibaraki 300-2635 Japan.

Huanxu Xie (H)

WuXi AppTec Company Ltd. 666 Gaoxin Road, East Lake High-Tech Development Zone Wuhan 430075 People's Republic of China.

Shuji Yonezawa (S)

Shionogi & Co., Ltd 3-1-1, Futaba-cho Toyonaka-shi Osaka Japan.

Osamu Yoshida (O)

Shionogi & Co., Ltd 3-1-1, Futaba-cho Toyonaka-shi Osaka Japan.

Ryu Yoshida (R)

Shionogi & Co., Ltd 3-1-1, Futaba-cho Toyonaka-shi Osaka Japan.

Charles Mowbray (C)

Drugs for Neglected Diseases initiative 15 Chemin Louis Dunant Geneva 1202 Switzerland bperry@dndi.org.

Benjamin Perry (B)

Drugs for Neglected Diseases initiative 15 Chemin Louis Dunant Geneva 1202 Switzerland bperry@dndi.org.

Classifications MeSH